Search

White stumpnose Rhabdosargus globiceps is the main target of the linefishery in Saldanha Bay. Increased fishing pressure over the last three decades, particularly by the recreational sector, has led to concerns regarding sustainability of the local white stumpnose stock. The fishery was exceptionally productive between 2006 and 2008, with an estimated annual catch of 141.2 tonnes (t). Only 3% of boat outings surveyed were commercial boats targeting white stumpnose, yet this sector accounted for 39.3 t (31%) of the average annual catch. The recreational boat sector accounted for most of the catch (70.0 t), and the recreational shore sector the least (31.9 t). Commercial boat catch per unit effort (CPUE; 3.7 fish angler–1 h–1) was more than 10 times that of recreational boats (0.3 fish angler–1 h–1). White stumpnose catch length-frequency differed significantly (p < 0.01) between the fishing sectors, with the commercial sector retaining larger fish (34.7 cm [SD 5.9]) than the recreational boat (33.9 cm [SD 5.9]) and shore (30.4 cm [SD 5.8]) sectors. A decline in commercial CPUE (2000–2015) of approximately 40% and a concomitant severe decline (>95%) in survey data for juvenile white stumpnose CPUE (2007–2016) indicate that the current rate of exploitation is not sustainable. Recovery of the white stumpnose stock will require a decrease in fishing mortality. Possible management regulations include sector-specific effort limitations, extending the ‘no take’ marine protected area, reducing the recreational-sector bag limit to 5 fish person–1 day–1, implementing a commercial-sector bag limit, and increasing the minimum size limit to 30 cm TL.Keywords: angling, annual yield, catch and effort, Langebaan Lagoon, linefish, recruitment survey, roving creel survey, temperate sparid

Background. Streptococci are not an infrequent cause of periprosthetic joint infection (PJI). Management by debridement, antibiotics, and implant retention (DAIR) is thought to produce a good prognosis, but little is known about the real likelihood of success. Methods. A retrospective, observational, multicenter, international study was performed during 2003-2012. Eligible patients had a streptococcal PJI that was managed with DAIR. The primary endpoint was failure, defined as death related to infection, relapse/persistence of infection, or the need for salvage therapy. Results. Overall, 462 cases were included (median age 72 years, 50% men). The most frequent species was Streptococcus agalactiae (34%), and 52% of all cases were hematogenous. Antibiotic treatment was primarily using β-lactams, and 37% of patients received rifampin. Outcomes were evaluable in 444 patients: Failure occurred in 187 (42.1%; 95% confidence interval, 37.5%-46.7%) after a median of 62 days from debridement; patients without failure were followed up for a median of 802 days. Independent predictors (hazard ratios) of failure were rheumatoid arthritis (2.36), late post-surgical infection (2.20), and bacteremia (1.69). Independent predictors of success were exchange of removable components (0.60), early use of rifampin (0.98 per day of treatment within the first 30 days), and long treatments (≥21 days) with β-lactams, either as monotherapy (0.48) or in combination with rifampin (0.34). Conclusions. This is the largest series to our knowledge of streptococcal PJI managed by DAIR, showing a worse prognosis than previously reported. The beneficial effects of exchanging the removable components and of β-lactams are confirmed and maybe also a potential benefit from adding rifampin. © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.